2026-10-12
Boehringer Ingelheim Establishes R&D Center in Shanghai, Enhances Early Clinical Development of New Drugs, Deepens External Innovation Collaboration
Boehringer Ingelheim announced the official completion of its newly established R&D center in Zhangjiang, Shanghai, marking a new phase in...